GYN cancer (ovarian, endometrial, or cervical) was biopsy-proven and/or schedule for subsequent surgery based on clinical presentation (imaging, markers)
Age ≥ 18 years.
Can tolerate 18F-fluciclovine PET/CT exam (can lie on her back for the duration of the scan).
Ability to understand and the willingness to sign a written informed consent.
You may not be if
Ongoing systemic therapy for cancer
Systemic therapy for cancer in the past 3 months
Inability to tolerate 18F-fluciclovine PET/CT exam
Pregnant or lactating women
Clareo Health | Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
